Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.
Men have two birth control options: condoms and vasectomies. Why has it taken so long to develop more contraceptives?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback